NEAT1 participates in cancer progression and therapeutic response under various conditions, and it seems to be an ideal prognostic marker for assessing hypoxic tumors due to its tumor-promoting role under hypoxia [58,65]. The gene discussed is NEAT1; the disease is cancer.